Barclays PLC Pfizer Inc Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Pfizer Inc stock. As of the latest transaction made, Barclays PLC holds 16,880,409 shares of PFE stock, worth $446 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
16,880,409
Previous 803,300
2001.38%
Holding current value
$446 Million
Previous $23.2 Million
1826.35%
% of portfolio
0.13%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding PFE
# of Institutions
3,367Shares Held
3.69BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.2 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.68 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$4.11 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA140MShares$3.7 Billion0.7% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $148B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...